课题基金 / 基金详情

Studies on the Development of Spray Influenza Vaccine Combined with an Adjuvant

Studies on the Development of Spray Influenza Vaccine Combined with an Adjuvant
佐剂喷雾型流感疫苗的研制
批准号:
01570260
负责人:
TAMURA Shin-ichi
金额:
$1.41万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1989
资助国家:
日本
项目状态:
已结题
起止时间:
1989 至 1990

项目摘要

项目成果

TAMURA Shin-ichi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Effects of intransal inoculation of influenza HA vaccine, together with cholera toxin B subunit (CTB), on antibody responses to virus antigens and on protection against viral challenge were investigated in Balb/c mice.(1) The vaccine inoculated with CTB induced high responses of both antiviral IgA antibodies in the nasal wash and haemagglutinin-inhibiting (HI) antibody in the serum, enough to provide complete protection against viral challenge 4 weeks after immunization. (2) High levels of antibody were maintained for more than 16 weeks after inoculation, affording complete protection during this interval. (3) The inoculation of HA vaccine prepared from a variant virus within the same subtype or a different subtype virus, together with CTB, provided partial protection against viral infection, with production of antiviral cross-reacting IgA antibodies. (4) The two-dose regimen, composed of a primary internasal inoculation of vaccine together with CTB and the subsequent inoculation of va … More ccine alone 4 weeks later, induced much higher responses of both antiviral IgA antibodies in nasal wash and HI antibody in serum, which persisted for more than 12 weeks after the second inoculation. This regimen provided not only complete protection against homologous virus infection, but also partial cross-protection against heterologous A-type virus infection, in parallel with high persistent levels of cross-reacting IgA antibodies.Intranasal inoculation of haemagglutinin (HA) molecules, purified from virus, together with CTB into mice resulted in complete protection against viral infection in parallel with the induction of high levels of HA-specific IgA-specific IgA and IgG antibodies on the respiratory tract. The respiratory tract IgA, purified from nasal and lung washings, included cross-reacting antibodies besides specific antibodies, which were not only higher in content in the nasal wash, but also more cross-reactive than IgG. When passively transferred to normal mouse before infection, the purified IgA protected against viral challenge.These results suggest that intranasal vaccination of CTB-combined influenza inactivated vaccine or HA molecules, which consists of different subtype viruses and different type viruses, is very useful for controlling the outbreaks of influenza by inducing locsl IgA antibodies. Less
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
Tamura, S.ーI.,et al.: "Enhancement of protective antibody responses by cholera toxin B subunit inoculated intranasally with influenza vaccine" Vaccine. 7. 257-262 (1989)
Tamura, S.-I. 等人:“通过鼻内接种流感疫苗来增强保护性抗体反应”疫苗。7. 257-262 (1989)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tamura, S.ーI., et al.: "Protection against influenza virus infection by a twoーdose regimen of nasal vaccination using vaccines combined with cholera toxin B subunit" Vaccine. 7. 314-320 (1989)
Tamura, S.-I. 等人:“通过使用与霍乱毒素 B 亚单位组合的疫苗进行两剂鼻疫苗接种方案来预防流感病毒感染”疫苗。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
12
    studies on the mechanism by which nasal influenza vaccine enhances the efficacy of protection
    • 批准号:
      03670241
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.34万
    • 财政年份:
      1991
    • 负责人:
      TAMURA Shin-ichi
    • 依托单位:
    海外基金